Looking into this for someone else

Someone you care about is unwell, and you want to be useful. You can look through what’s recruiting in Canada, keep what seems worth a second look, and send it to them or their doctor in one message.

Whether they follow any of it up is theirs to decide.

A Care Package is a note you put together

As you look, keep the trials that seem worth a second look. When you’re ready, they go to the person you’re thinking of — or to their doctor — as one plain-language note, in your words. Nothing is sent until you say so.

  1. LookBrowse what’s recruiting in Canada.
  2. KeepSave the ones worth a second look.
  3. SendOne note, in your words, when you’re ready.

Whether they read it, or do anything with it, is entirely theirs. You don’t need their details to do any of this.

86 trials matching “Lung Cancer” · showing 30

Comparing Sacituzumab tirumotecan with Pembrolizumab for non-small cell lung cancer (NSCLC)

Explore this study →

There are 2 groups in this study. Group A receives Pembrolizumab and Sacituzumab tirumotecan, together with one or more of: Supportive care measures. Group B, the comparison group, receives Pembrolizumab, together with one or more of: Supportive care measures.

Sites in Brampton, Mississauga and 1 more city

  • Phase 3
  • 2 groups
  • Sites in Brampton, Mississauga and 1 more city
  • Recruiting

Official title: Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Non-small Cell Lung Cancer (NSCLC) · Merck Sharp & Dohme LLC

Comparing Intismeran autogene with Pembrolizumab for non-small-cell lung carcinoma

Explore this study →

There are 2 groups in this study. Group A receives Pembrolizumab and Intismeran autogene, together with one or more of: Cisplatin, Carboplatin, Pemetrexed, Gemcitabine and Paclitaxel. Group B, the comparison group, receives Pembrolizumab and Placebo, together with one or more of: Cisplatin, Carboplatin, Pemetrexed, Gemcitabine and Paclitaxel.

Sites in Halifax, Hamilton and 5 more cities

  • Phase 3
  • 2 groups
  • Sites in Halifax, Hamilton and 5 more cities
  • Recruiting

Official title: A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Carcinoma, Non-Small-Cell Lung · Merck Sharp & Dohme LLC

Looking for the closest fit?

Get matched →

Ask someone to look with you

Whether or not the results above are what you were looking for, someone at Concord can search with you.

Concord provides information only. Trial listings come from public registries, and whether anyone can take part is decided by the trial site and their own care team.